Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005801 · ClinicalTrials.gov registry record · Phase 2
Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005801: Completed Phase 2 study, sponsored by University of Colorado, Denver.
NCT00005801 is a Phase 2 study that has completed, run by University of Colorado, Denver. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005801, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by radiation therapy used to kill tumor cells. Infusions of donor white blood cells may decrease the body's rejection of the transplanted peripheral stem cells. PURPOSE: Phase II trial to study the effectiveness of combining radiation therapy, peripheral stem cell transplantation, and donor white blood cell infusions in treating older patients who have acute myeloid leukemia.
Interventions
- RADIATION radiation therapy
- PROCEDURE peripheral blood stem cell transplantation
- BIOLOGICAL therapeutic allogeneic lymphocytes
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-11 |
| Est. Completion | 2001-09 |
| Phase | Phase 2 |
What the finished NCT00005801 record still lists
NCT00005801 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which radiation therapy is the first listed.
NCT00005801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005801 about?
NCT00005801 is a clinical study titled "Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by radiation therapy used to kill tumor cells. Infusions of donor white blood cells may decrease the body's rejection of the transp...
What is the current status of trial NCT00005801?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-11. Estimated completion is 2001-09.
What interventions are being tested in trial NCT00005801?
The interventions under investigation include: radiation therapy (RADIATION), peripheral blood stem cell transplantation (PROCEDURE), therapeutic allogeneic lymphocytes (BIOLOGICAL).
Who is sponsoring clinical trial NCT00005801?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia